rs4986942

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000406.3(GNRHR):​c.453C>T​(p.Ser151Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0859 in 1,613,558 control chromosomes in the GnomAD database, including 6,507 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.085 ( 638 hom., cov: 32)
Exomes 𝑓: 0.086 ( 5869 hom. )

Consequence

GNRHR
NM_000406.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.13

Publications

14 publications found
Variant links:
Genes affected
GNRHR (HGNC:4421): (gonadotropin releasing hormone receptor) This gene encodes the receptor for type 1 gonadotropin-releasing hormone. This receptor is a member of the seven-transmembrane, G-protein coupled receptor (GPCR) family. It is expressed on the surface of pituitary gonadotrope cells as well as lymphocytes, breast, ovary, and prostate. Following binding of gonadotropin-releasing hormone, the receptor associates with G-proteins that activate a phosphatidylinositol-calcium second messenger system. Activation of the receptor ultimately causes the release of gonadotropic luteinizing hormone (LH) and follicle stimulating hormone (FSH). Defects in this gene are a cause of hypogonadotropic hypogonadism (HH). Alternative splicing results in multiple transcript variants encoding different isoforms. More than 18 transcription initiation sites in the 5' region and multiple polyA signals in the 3' region have been identified for this gene. [provided by RefSeq, Jul 2008]
UBA6-DT (HGNC:49083): (UBA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 4-67753883-G-A is Benign according to our data. Variant chr4-67753883-G-A is described in ClinVar as [Benign]. Clinvar id is 349456.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNRHRNM_000406.3 linkc.453C>T p.Ser151Ser synonymous_variant Exon 1 of 3 ENST00000226413.5 NP_000397.1 P30968-1
GNRHRNM_001012763.2 linkc.453C>T p.Ser151Ser synonymous_variant Exon 1 of 3 NP_001012781.1 P30968-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNRHRENST00000226413.5 linkc.453C>T p.Ser151Ser synonymous_variant Exon 1 of 3 1 NM_000406.3 ENSP00000226413.5 P30968-1

Frequencies

GnomAD3 genomes
AF:
0.0853
AC:
12979
AN:
152130
Hom.:
636
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.172
Gnomad AMR
AF:
0.0875
Gnomad ASJ
AF:
0.0879
Gnomad EAS
AF:
0.00635
Gnomad SAS
AF:
0.0534
Gnomad FIN
AF:
0.0282
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0892
Gnomad OTH
AF:
0.0823
GnomAD2 exomes
AF:
0.0755
AC:
18921
AN:
250604
AF XY:
0.0736
show subpopulations
Gnomad AFR exome
AF:
0.104
Gnomad AMR exome
AF:
0.0934
Gnomad ASJ exome
AF:
0.0839
Gnomad EAS exome
AF:
0.00571
Gnomad FIN exome
AF:
0.0325
Gnomad NFE exome
AF:
0.0905
Gnomad OTH exome
AF:
0.0798
GnomAD4 exome
AF:
0.0859
AC:
125590
AN:
1461310
Hom.:
5869
Cov.:
32
AF XY:
0.0843
AC XY:
61318
AN XY:
727010
show subpopulations
African (AFR)
AF:
0.102
AC:
3421
AN:
33476
American (AMR)
AF:
0.0941
AC:
4203
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0848
AC:
2216
AN:
26128
East Asian (EAS)
AF:
0.00658
AC:
261
AN:
39690
South Asian (SAS)
AF:
0.0533
AC:
4600
AN:
86250
European-Finnish (FIN)
AF:
0.0362
AC:
1932
AN:
53384
Middle Eastern (MID)
AF:
0.0883
AC:
509
AN:
5764
European-Non Finnish (NFE)
AF:
0.0932
AC:
103589
AN:
1111594
Other (OTH)
AF:
0.0805
AC:
4859
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
5882
11765
17647
23530
29412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3854
7708
11562
15416
19270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0854
AC:
13002
AN:
152248
Hom.:
638
Cov.:
32
AF XY:
0.0812
AC XY:
6046
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.105
AC:
4346
AN:
41542
American (AMR)
AF:
0.0878
AC:
1342
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0879
AC:
305
AN:
3470
East Asian (EAS)
AF:
0.00637
AC:
33
AN:
5182
South Asian (SAS)
AF:
0.0539
AC:
260
AN:
4828
European-Finnish (FIN)
AF:
0.0282
AC:
299
AN:
10616
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0892
AC:
6066
AN:
68000
Other (OTH)
AF:
0.0814
AC:
172
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
596
1191
1787
2382
2978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0915
Hom.:
1245
Bravo
AF:
0.0925
Asia WGS
AF:
0.0420
AC:
148
AN:
3478
EpiCase
AF:
0.0939
EpiControl
AF:
0.0881

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 27, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypogonadotropic hypogonadism 7 with or without anosmia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
4.0
DANN
Benign
0.50
PhyloP100
1.1
PromoterAI
-0.065
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4986942; hg19: chr4-68619601; COSMIC: COSV56933637; API